The multiyear ORBEX clinical trial found that OM-85 did not reduce severe wheezing episodes or early childhood asthma ...

Classroom dust containing elevated levels of certain bacteria was tied to measurable reductions in lung function among school ...

Artificial intelligence chatbots incorrectly reassured obstructive sleep apnea (OSA) patients that their symptoms were not ...

Medibyt's CPETWise automated platform aims to cut cardiopulmonary exercise testing interpretation time in half and ...

A national study reveals fewer pediatricians report emotional exhaustion, though overall burnout prevalence in healthcare ...

AAP recommendations expand second-season RSV protection criteria for children ages 8 to 19 months, plus infant COVID-19 ...

Targeting key cellular proteins may provide new opportunities to diagnose, prevent, and treat pulmonary arterial hypertension ...

IDSA recommendations emphasize the safety and importance of COVID-19, influenza, and RSV vaccines immunocompromised patients.

GE HealthCare issued updated use instructions for certain patient monitoring devices, according to an FDA alert.

Draeger issued a letter to affected customers recommending certain VentStar Resus Neo hoses be removed from where they are ...

FDA will review Enflonsia's ability to protect high-risk children under 2 years of age during their second RSV season.

Inhalation Solution would become the first inhaled option designed to treat idiopathic pulmonary fibrosis (IPF).